Literature DB >> 9837863

Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.

W R Ji1, F J Castellino, Y Chang, M E Deford, H Gray, X Villarreal, M E Kondri, D N Marti, M Llinás, J Schaller, R A Kramer, P A Trail.   

Abstract

Angiogenesis is a complex process that involves endothelial cell proliferation, migration, basement membrane degradation, and neovessel organization. Angiostatin, consisting of four homologous triple-disulfide bridged kringle domains, has previously been shown to exhibit profound inhibition of endothelial cell proliferation in vitro and angiogenesis in vivo. It was also demonstrated that angiostatin could suppress the growth of a variety of tumors via the blocking of angiogenesis. The primary aim of our study was to characterize the kringle domains of angiostatin for their inhibitory activities of endothelial cell migration in order to elucidate their contributions to the anti-angiogenic function of angiostatin. In this report, we demonstrate for the first time that the kringles of angiostatin play different roles in inhibiting endothelial cell migration, a crucial process in angiogenesis. Kringle 4, which has only marginal anti-proliferative activity, is among the most potent fragments in inhibiting endothelial cell migration (IC50 of approximately 500 nM). In contrast, kringle 1-3, which is equivalent to angiostatin in inhibiting endothelial cell proliferation, manifests only a modest anti-migratory effect. The combination of kringle 1-3 and kringle 4 results in an anti-migratory activity comparable to that of angiostatin. When kringle 1 is removed from kringle 1-3, the resulting kringle 2-3 becomes more potent than kringle 1-3. This implies that kringle 1, although virtually ineffective in inhibiting endothelial cell migration, may influence the conformation of kringle 1-3 to alter its anti-migratory activity. We also show that disruption of the kringle structure by reducing/alkylating agents markedly attenuates the anti-migratory activity of angiostatin, demonstrating the significance of kringle conformation in maintaining the anti-angiogenic activity of angiostatin. Our data suggest that different kringle domains may contribute to the overall anti-angiogenic function of angiostatin by their distinct anti-migratory activities.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9837863     DOI: 10.1096/fasebj.12.15.1731

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  25 in total

1.  An Inhibitor of the F1 subunit of ATP synthase (IF1) modulates the activity of angiostatin on the endothelial cell surface.

Authors:  Nick R Burwick; Miriam L Wahl; Jun Fang; Zhaoxi Zhong; Tammy L Moser; Bo Li; Roderick A Capaldi; Daniel J Kenan; Salvatore V Pizzo
Journal:  J Biol Chem       Date:  2004-11-04       Impact factor: 5.157

2.  Recombinant human prothrombin kringle-2 inhibits B16F10 melanoma metastasis through inhibition of neovascularization and reduction of matrix metalloproteinase expression.

Authors:  Tae Hyong Kim; Sookyung Ahn; Jaebeum Kim; Ilhan Kim; Mei Zi Yang; Jong Eun Lee; Soung Soo Kim
Journal:  Clin Exp Metastasis       Date:  2006-12-23       Impact factor: 5.150

3.  Anti-tumoural effects of PlgK1-5 are directly linked to reduced ICAM expression, resulting in hepatoma cell apoptosis.

Authors:  Volker Schmitz; Tilman Sauerbruch; Esther Raskopf
Journal:  Int J Colorectal Dis       Date:  2012-03-28       Impact factor: 2.571

Review 4.  The essential anti-angiogenic strategies in cartilage engineering and osteoarthritic cartilage repair.

Authors:  Song Chen; Yixuan Amy Pei; Ming Pei
Journal:  Cell Mol Life Sci       Date:  2022-01-14       Impact factor: 9.261

5.  Soluble melanoma cell adhesion molecule (sMCAM/sCD146) promotes angiogenic effects on endothelial progenitor cells through angiomotin.

Authors:  Jimmy Stalin; Karim Harhouri; Lucas Hubert; Caroline Subrini; Daniel Lafitte; Jean-Claude Lissitzky; Nadia Elganfoud; Stéphane Robert; Alexandrine Foucault-Bertaud; Elise Kaspi; Florence Sabatier; Michel Aurrand-Lions; Nathalie Bardin; Lars Holmgren; Françoise Dignat-George; Marcel Blot-Chabaud
Journal:  J Biol Chem       Date:  2013-02-06       Impact factor: 5.157

6.  Notochord-derived BMP antagonists inhibit endothelial cell generation and network formation.

Authors:  Michael Bressan; Patricia Davis; John Timmer; Doris Herzlinger; Takashi Mikawa
Journal:  Dev Biol       Date:  2008-11-12       Impact factor: 3.582

7.  Specific endothelial binding and tumor uptake of radiolabeled angiostatin.

Authors:  Kyung-Han Lee; Sung Hee Song; Jin-Young Paik; Sang Sung Byun; Sang-Yoon Lee; Yearn Seong Choe; Byung-Tae Kim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-30       Impact factor: 9.236

8.  Suppression of renal cell carcinoma growth and metastasis with sustained antiangiogenic gene therapy.

Authors:  Matthew J Mellon; Kyung-Hee Bae; Catherine E Steding; Juan A Jiménez; Chinghai Kao; Thomas A Gardner
Journal:  Hum Gene Ther       Date:  2008-05       Impact factor: 5.695

9.  Angiostatin inhibits experimental liver fibrosis in mice.

Authors:  J Mathys Vogten; Tamas A Drixler; Elisabeth A te Velde; Marguerite E Schipper; Theo J M V van Vroonhoven; Emile E Voest; Inne H M Borel Rinkes
Journal:  Int J Colorectal Dis       Date:  2004-01-10       Impact factor: 2.571

10.  The Kringle of Life.

Authors:  Manuel Llinás
Journal:  Protein J       Date:  2021-06-16       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.